A 3D QSAR study was performed on 1,2,4-oxadiazole derivatives using the [(SW) kNN MFA], CoMFA, and CoMSIA techniques. On the basis of 3D QSAR outcomes, new molecules were designed by substituting different substituents. These designed compounds were synthesized and confirmed their synthesis by spectroscopic techniques. The synthesized compounds were screened for their anticancer activity against different cancer cell lines. Compound 2-[3-(pyridine-4-yl)-1,2,4-oxadiazol-5-yl]benzo[d]thiazole showed equipotent (IC50 = 4.96 μM) as 5-fluorouracil (IC50 = 3.2 μM) against colon (CaCo-2) cancer cell line, and compound [2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]benzo[d]thiazol-4-yl]methanol showed equipotent activity (IC50 = 0.35 μM) as compared to 5-fluorouracil (IC50 = 0.23 μM) against colorectal (DLD1) cancer cell line. Compound 2-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]benzo[d]thiazole was found to be 4–5 less potent (IC50 = 19.40 μM) as paclitaxel (IC50 = 4.10 μM) against breast (T47D) cancer cell line, and compound 4-[5-(benzo[d]thiazol-2-yl)-1,2,4-oxadiazol-3-yl]benzene-1,2-diol was found about 10 times less potent (IC50 = 15.7 μM) than mitomycin (IC50 = 1.50 μM) against prostate (PC-3) cancer cell line. These results disclose the discovery of new 1,2,4-oxadiazole-based anticancer drugs.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Carson DA, Ribeiro JM (1993) Lancet 341:1251
Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE (2006) J Natl Cancer Inst 98:691
Suk OY, Young KH, Jin JS, Young PK, Young KS, Jung LH, Ok LE, Seok AK, Hoon KS (2009) Chin Sci Bull 54:387
Sohn EJ, Li H, Reidy K, Beers LF, Christensen BL, Lee SB (2010) Cancer Res 70:115
Zhang HZ, Kashibhatla S, Guastella J, Drew J, Tseng B, Cai SX (2003) Bioconjug Chem 14:458
Silva SRD, Bacchi MM, Bacchi CE, Oliveira DED (2007) Am J Clin Pathol 128:794
Thornberry NA (1998) Chem Biol 5:97
Syed FM, Hahn HS, Odley A, Guo Y, Vallejo JG, Lynch RA, Mann DL, Bolli R, Dorn GW (2005) Circ Res 96:1103
Mohr A, Zwacka RM (2007) Cell Biol Int 31:526
Marques CA, Keil U, Bonert A, Steiner B, Haass C, Muller WE, Eckert A (2003) J Biol Chem 278:28294
Salvesen GS, Dixit VM (1997) Cell 91:443
Cai SX, Zhang HZ, Guastella J, Drew J, Yang W, Weber E (2001) Bioorg Med Chem Lett 11:39
Jänicke RU (2008) Breast Can Res Treat 117:219
Jain AK, Veerasamy R, Vaidya A, Mourya V, Agrawal RK (2010) Med Chem Res 19:1191
Vaidya A, Jain S, Jain S, Jain AK, Agrawal RK (2014) J Pharm Sci Pharmacol 1:219
Yuan H, Pavel PA (2006) Bioorg Med Chem Lett 16:6267
Ravichandran V, Jain PK, Mourya VK, Agrawal RK (2007) Med Chem Res 16:342
Gupta SP, Babu MS, Garg R, Sowmya S (1998) J Enzyme Inhib 13:399
Duchowicz PR, Fernandez M, Carballero J, Castro EA, Fernandez FM (2006) Bioorg Med Chem 14:5876
Leonard JT, Roy K (2006) Bioorg Med Chem 14:1039
Ravichandran V, Agrawal RK (2007) Bioorg Med Chem Lett 17:2197
Prashanthakumar BR, Nanjan MJ (2010) Med Chem Res 19:1000
Prashanthakumar BR, Sankar G, Baig RBN, Chandrashekaran S (2009) Eur J Med Chem 44:4192
Vaidya A, Jain AK, Prashanthakumar BR, Kashaw SK, Agrawal RK (2011) J Enzyme Inhib Med Chem 26:854
Vaidya A, Jain S, Jain AK, Prashanthakumar BR, Kashaw SK, Agrawal RK (2015) Med Chem Res 24:383
V-Life Molecular Design Suite 3.0, VLife Sciences Technologies Pvt. Ltd; Baner Road: Pune, Maharashtra, India. www.Vlifesciences.com. Accessed Jan 2019
Nandi S, Bagchi MC (2010) Mol Divers 14:27
Vaidya A, Jain AK, Prashanthakumar BR, Sastry GN, Kashaw SK, Agrawal RK (2017) Arab J Chem 10:S3936
Zhang HZ, Kaisbhatla S, Kuemmerle J, Kemnitzer W, Mason KO, Qui L, Grundy CC, Tseng B, Drew J, Cai SX (2005) J Med Chem 48:5215
Kemnitzer W, Kuemmerle J, Zhang HZ, Kaisbhatla S, Tseng B, Drew J, Cai SX (2009) Bioorg Med Chem Lett 19:4410
Vaidya A, Jain S, Jain P, Jain P, Tiwari N, Jain R, Jain R, Jain AK, Agrawal RK (2016) Mini Rev Med Chem 16:825
We would like to thank Principal JSS College of Pharmacy, Ooty, India, for providing access to computational resources and for their valuable help during the modeling studies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Vaidya, A., Jain, S., Prashantha Kumar, B. et al. Synthesis of 1,2,4-oxadiazole derivatives: anticancer and 3D QSAR studies. Monatsh Chem (2020). https://doi.org/10.1007/s00706-020-02553-1
- [(SW) kNN MFA]
- Anticancer activity